作者：
Marie Jo,Halaby [1]
;
Kebria,Hezaveh [2]
;
Sara,Lamorte [1]
;
M Teresa,Ciudad [2]
;
Andreas,Kloetgen [1]
;
Bethany L,MacLeod [2]
;
Mengdi,Guo [1]
;
Ankur,Chakravarthy [2]
;
Tiago Da Silva,Medina [3]
;
Stefano,Ugel [1]
;
Aristotelis,Tsirigos [2]
;
Vincenzo,Bronte [1]
;
David H,Munn [2]
;
Trevor J,Pugh [4]
;
Daniel D,De Carvalho [5]
;
Marcus O,Butler [6]
;
Pamela S,Ohashi [3]
;
David G,Brooks [7]
;
Tracy L,McGaha [8]
作者单位：
Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
[1]
Department of Immunology, University of Toronto, Toronto, ON, Canada.
[2]
Department of Pathology, New York University School of Medicine, New York, NY, USA.
[3]
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
[4]
A.C. Camargo Cancer Center, Sao Paulo, Brazil.
[5]
Department of Medicine, Immunology Section, Verona University Hospital, Verona, Italy.
[6]
Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA.
[7]
Applied Bioinformatics Laboratories, New York University School of Medicine, New York, NY, USA.
[8]
Department of Pediatrics, Medical College of Georgia, Augusta, GA, USA.
[9]
Georgia Cancer Center, Augusta, GA, USA.
[10]
Ontario Institute for Cancer Research, Toronto, ON, Canada.
[11]
Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. tmcgaha@uhnresearch.ca.
[12]
DOI
10.1126/sciimmunol.aax8189
PMID
31836669
发布时间
2021-12-04
换一批
换一批
